These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25318807)

  • 1. Patient with neuromyelitis optica spectrum disorder combined with Sjögren's syndrome relapse free following tacrolimus treatment.
    Zheng X; Zhang X; Liu X; Mu W; Yang W; Liu Y; Ge P; Li H
    Intern Med; 2014; 53(20):2377-80. PubMed ID: 25318807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sjögren's syndrome and neuromyelitis optica spectrum disorders (NMOSD)--a case report and review of literature.
    Jayarangaiah A; Sehgal R; Epperla N
    BMC Neurol; 2014 Oct; 14():200. PubMed ID: 25291981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience.
    Martín-Nares E; Hernandez-Molina G; Fragoso-Loyo H
    Lupus; 2019 Oct; 28(11):1302-1311. PubMed ID: 31566079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica and non organ-specific autoimmunity.
    Pittock SJ; Lennon VA; de Seze J; Vermersch P; Homburger HA; Wingerchuk DM; Lucchinetti CF; Zéphir H; Moder K; Weinshenker BG
    Arch Neurol; 2008 Jan; 65(1):78-83. PubMed ID: 18195142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuromyelitis optica spectrum disorders as initial presentation of Sjögren's syndrome: A case report].
    Alva Díaz C; Andamayo Villalba L; Mori N; Ventura Chilón JJ; Romero R
    Medwave; 2016 Feb; 16(1):e6388. PubMed ID: 26938585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report.
    Komai T; Shoda H; Yamaguchi K; Sakurai K; Shibuya M; Kubo K; Takahashi T; Fujio K; Yamamoto K
    Mod Rheumatol; 2016; 26(2):294-6. PubMed ID: 24313919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
    Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
    J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjögren's syndrome.
    Kahlenberg JM
    Semin Arthritis Rheum; 2011 Feb; 40(4):343-8. PubMed ID: 20655576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of anti-SSA/Ro antibody in Neuromyelitis optica spectrum disorders.
    Lin L; Hang H; Zhang J; Lu J; Chen D; Shi J
    Mult Scler Relat Disord; 2022 Feb; 58():103494. PubMed ID: 35051897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu.
    Carvalho DC; Tironi TS; Freitas DS; Kleinpaul R; Talim NC; Lana-Peixoto MA
    Arq Neuropsiquiatr; 2014 Aug; 72(8):619-24. PubMed ID: 25098478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica--complication or comorbidity in primary Sjögren's syndrome?
    Niţescu D; Nicolau A; Caraiola S; Predeţeanu D; Ionescu R; Tănăsescu C
    Rom J Intern Med; 2011; 49(4):295-300. PubMed ID: 22568275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of presentations and outcomes of neuromyelitis optica patients with and without Sjögren's syndrome.
    Zhong YH; Zhong ZG; Zhou Z; Ma ZY; Qiu MY; Peng FH; Zhang WX
    Neurol Sci; 2017 Feb; 38(2):271-277. PubMed ID: 27817092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of neuromyelitis optica spectrum disorder (NMOSD) with Sjögren's syndrome manifested only brain involvement by preceding parotitis].
    Furukawa T; Matsui N; Tanaka K; Izumi Y; Kaji R
    Rinsho Shinkeigaku; 2017 Feb; 57(2):77-81. PubMed ID: 28132975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-A immunoadsorption combined with immunosuppressive treatment in refractory primary Sjögren's syndrome coexisting with NMOSD: a case report and literature review.
    Fan W; Chen X; Xiao P; Wei B; Zhang Y; Huang J; Wu S; Lu L
    Front Immunol; 2024; 15():1429405. PubMed ID: 39055718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
    Yaguchi H; Sakushima K; Takahashi I; Nishimura H; Yashima-Yamada M; Nakamura M; Tsuzaka K; Maruo Y; Takahashi T; Yabe I; Sasaki H
    Intern Med; 2013; 52(9):969-72. PubMed ID: 23648715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Relapse After Cessation of Immunosuppressive Therapy in a Patient With Neuromyelitis Optica Spectrum Disorder.
    Hyun JW; Kim G; Kim Y; Jeong IH; Kim SH; Kim HJ
    Neurologist; 2016 Nov; 21(6):97-98. PubMed ID: 27801768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent optic neuritis in a patient with Sjogren syndrome and neuromyelitis optica spectrum disorder: A case report.
    Zheng W; Liu X; Hou X; Zhu Y; Zhang T; Liao L
    Medicine (Baltimore); 2020 Nov; 99(45):e23029. PubMed ID: 33157952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article.
    Qiao L; Wang Q; Fei Y; Zhang W; Xu Y; Zhang Y; Zhao Y; Zeng X; Zhang F
    Medicine (Baltimore); 2015 Jul; 94(28):e1145. PubMed ID: 26181553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromyelitis optica spectrum disorder complicated with Sjögren's syndrome: first pediatric case responsive to mycophenolate mofetil treatment.
    Fang GL; Fang W; Zheng Y; Zhang YX
    Acta Neurol Belg; 2021 Aug; 121(4):1065-1067. PubMed ID: 33136271
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship Between Neuromyelitis Optica Spectrum Disorder and Sjögren's Syndrome: Central Nervous System Extraglandular Disease or Unrelated, Co-Occurring Autoimmunity?
    Birnbaum J; Atri NM; Baer AN; Cimbro R; Montagne J; Casciola-Rosen L
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1069-1075. PubMed ID: 27696784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.